Small Caps | 1:47 PM
Analysts' assessments vary markedly on the impact on Pexa Group from potential regulatory reform.
- IPART review raises uncertainty over Pexa Group's pricing ability
- Asset-based framework has potential to reshape returns
- Jarden sees potential pricing reductions of between -25%-47%
- Cost-out might offset some or all of price cuts
By Mark Woodruff
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE